fda changes to semaglutide just got FDA-approved for kidney disease. This everything., January 2025. The approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in Maximizing Semaglutide: Understanding the Doses

Partial deletion of the cAMP response element-binding protein gene promotes alcohol-drinking behaviors

[1] Researchers report that the peptide exhibited equivalent or better performance using two recombinant CHO cell lines. IGF-1 LR3 may be more capable of inducing the type 1 IGF receptor, potentially promoting an elevated level of intracellular signaling, cellular proliferation, and apoptosis inhibition

Hypothesis 3 Glycemic control beyond retatrutide alone Cagrilintide adds postprandial glucagon suppression a mechanism retatrutide does not engage

GLP-1RAs may improve BMD, bone strength and bone microstructure and reversed GIOP, primarily through slow down of bone resorption and promotion of bone formation and osteogenic differentiation

AEDG peptide regulation of the expression of human circadian rhythm genes upon accelerated aging of the pineal gland